GAMMA Investing LLC Has $122.68 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

GAMMA Investing LLC boosted its position in HealthEquity, Inc. (NASDAQ:HQY) by 11,024.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 138,829 shares of the company’s stock after purchasing an additional 137,581 shares during the period. GAMMA Investing LLC owned about 0.16% of HealthEquity worth $122,680,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of HQY. Barclays PLC lifted its position in HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after acquiring an additional 112,667 shares during the last quarter. Janney Montgomery Scott LLC lifted its position in HealthEquity by 8.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 5,352 shares of the company’s stock worth $514,000 after acquiring an additional 420 shares during the last quarter. KBC Group NV lifted its position in HealthEquity by 56.7% during the fourth quarter. KBC Group NV now owns 3,860 shares of the company’s stock worth $370,000 after acquiring an additional 1,397 shares during the last quarter. Greenleaf Trust acquired a new stake in HealthEquity during the fourth quarter worth approximately $214,000. Finally, GDS Wealth Management lifted its position in HealthEquity by 43.6% during the fourth quarter. GDS Wealth Management now owns 41,131 shares of the company’s stock worth $3,947,000 after acquiring an additional 12,493 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HQY. The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday, March 27th. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Wells Fargo & Company lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Barrington Research reaffirmed an “outperform” rating and issued a $112.00 price objective on shares of HealthEquity in a report on Friday, April 11th. Finally, KeyCorp dropped their price objective on HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $112.33.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.

HealthEquity Stock Up 0.1%

Shares of HQY opened at $101.11 on Monday. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a market cap of $8.75 billion, a P/E ratio of 92.76, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a 50 day simple moving average of $89.41 and a two-hundred day simple moving average of $97.49.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.